HomeClinics HomeAbout ClinicsAll ClinicsHot TopicsAdvancesSpecial OffersCME
Logo
Search for

Volume 42, Issue 5, Pages 793-806 (September 2004)


View previous. 13 of 18 View next.

The randomized trials of breast cancer screening: what have we learned?

Robert A. Smith, PhDaCorresponding Author Informationemail address, Stephen W. Duffy, MScb, Rhian Gabe, MPhilb, Laszlo Tabar, MDc, Amy M.F. Yen, MScb, Tony H.H. Chen, PhDd

Eight randomized controlled trials of mammography screening have been conducted to date. In addition to evaluating the efficacy of screening with an experimental design, the trials provided investigators with access to information about breast cancers much earlier in their development than had previously been available. The trials of mammographic screening provide conclusive evidence that the policy of offering screening is associated with a significant and substantial reduction in breast cancer mortality.

a American Cancer Society, 1599 Clifton Road, NE, Atlanta, GA 30329, USA

b Cancer Research UK, Department of Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Mile End Road, Charterhouse Square, London E1 4NS, UK

c Mammography Department, Central Hospital, Falun S-79182, Sweden

d Institute of Preventive Medicine, National Taiwan University, No. 1, Section 4, Roosevelt Road, Taiwan

Corresponding Author InformationCorresponding author

PII: S0033-8389(04)00088-0

doi:10.1016/j.rcl.2004.06.014


View previous. 13 of 18 View next.